Bill > HB3168

This bill creates the Retail Sale of Tianeptine Prohibition Act, which will prohibit the sale, offering for sale, or distribution of any product containing tianeptine (a potentially addictive and harmful substance) in Illinois beginning January 1, 2026. The prohibition specifically does not apply to tianeptine products that are lawfully dispensed or prescribed by licensed health care professionals, which are defined as any person who treats human ailments and is subject to state licensure or regulation, including medical students and residents. Violations of this prohibition will be considered a business offense, with a mandatory minimum fine of $1,500 for each individual violation. The legislation aims to restrict public access to tianeptine, which has been associated with potential health risks, by preventing its retail sale while maintaining a pathway for legitimate medical use under professional supervision.

Government Affairs

https://www.ilga.gov/legislation/BillStatus.asp?DocNum=3168&GAID=18&DocTypeID=HB&SessionID=114&GA=104